A phase Ib/IIa trial of 9 repurposed drugs combined with temozolomide for the treatment of recurrent glioblastoma: CUSP9v3

Halatsch, M.-E., Kast, R. E., Karpel-Massler, G., Mayer, B., Zolk, O., Schmitz, B., Scheuerle, A., Maier, L., Bullinger, L., Mayer-Steinacker, R., Schmidt, C., Zeiler, K., Elshaer, Z., Panther, P., Schmelzle, B., Hallmen, A., Dwucet, A., Siegelin, M. D., Westhoff, M.-A., … Heiland, T. (2021). A phase Ib/IIa trial of 9 repurposed drugs combined with temozolomide for the treatment of recurrent glioblastoma: CUSP9v3. Neuro-Oncology Advances, 3(1). https://doi.org/10.1093/noajnl/vdab075
Authors:
Marc-Eric Halatsch
Richard E Kast
Georg Karpel-Massler
Benjamin Mayer
Oliver Zolk
Bernd Schmitz
Angelika Scheuerle
Ludwig Maier
Lars Bullinger
Regine Mayer-Steinacker
Carl Schmidt
Katharina Zeiler
Ziad Elshaer
Patricia Panther
Birgit Schmelzle
Anke Hallmen
Annika Dwucet
Markus D Siegelin
Mike-Andrew Westhoff
Kristine Beckers
Gauthier Bouche
Tim Heiland
Affiliated Authors:
Markus D Siegelin
Author Keywords:
chemotherapy
clinical trial
drug repurposing
glioblastoma
multi-drug combination
Publication Type:
Article
Unique ID:
10.1093/noajnl/vdab075
PMID:
Publication Date:
Data Source:
PubMed

Record Created: